These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29869567)

  • 21. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy.
    Li F; Huang Z; Chen H; Yan L; Li J; Su Y; Zhang Q; Huang Z; Zheng Y
    Drug Deliv; 2019 Dec; 26(1):1068-1079. PubMed ID: 31735094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
    Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
    Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
    He W; Du Y; Zhou W; Wang T; Li M; Li X
    Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
    He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
    Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
    Yang A; Liu Z; Yan B; Zhou M; Xiong X
    Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel sialic acid-conjugated camptothecin prodrug for enhanced cancer chemotherapy.
    Dong H; Huang X; Wu X
    Biomater Sci; 2023 Sep; 11(18):6160-6166. PubMed ID: 37548235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug.
    Lee MH; Kim JY; Han JH; Bhuniya S; Sessler JL; Kang C; Kim JS
    J Am Chem Soc; 2012 Aug; 134(30):12668-74. PubMed ID: 22642558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Starburst Diblock Polyprodrugs: Reduction-Responsive Unimolecular Micelles with High Drug Loading and Robust Micellar Stability for Programmed Delivery of Anticancer Drugs.
    Shi X; Hou M; Ma X; Bai S; Zhang T; Xue P; Zhang X; Liu G; Kang Y; Xu Z
    Biomacromolecules; 2019 Mar; 20(3):1190-1202. PubMed ID: 30658038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.
    Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-Carboxyphenylboronic acid-decorated, redox-sensitive rod-shaped nano-micelles fabricated through co-assembling strategy for active targeting and synergistic co-delivery of camptothecin and gemcitabine.
    Xu Y; Huang Y; Lu W; Liu S; Xiao Y; Yu J
    Eur J Pharm Biopharm; 2019 Nov; 144():193-206. PubMed ID: 31560954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox-sensitive dimeric camptothecin phosphatidylcholines-based liposomes for improved anticancer efficacy.
    He W; Du Y; Zhou W; Yao C; Li X
    Nanomedicine (Lond); 2019 Dec; 14(23):3057-3074. PubMed ID: 31696756
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
    Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
    Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
    Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
    Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
    Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y
    Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
    Tian H; Huang Y; He J; Zhang M; Ni P
    ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
    Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
    Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Camptothecin-based prodrug nanomedicines for cancer therapy.
    Zhang R; Yu J; Guo Z; Jiang H; Wang C
    Nanoscale; 2023 Nov; 15(44):17658-17697. PubMed ID: 37909755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.